MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202611106950 A) filed by Rupa Mazumder; Dr. Abhijit Debnath; Mr. Mohit Sharma; Dr. Chandana Majee; Mrs. Neha Sharma; Dr. Swarupanjali Padhi; Mrs. Archana Sharma; and Mrs. Nidhi Sharma on September 05, 2026, for Hydrogel Formulation Of Apigenin And Kaempferol Against Ulcerative Colitis And A Process For Preparing Thereof.
Inventors include Rupa Mazumder; Dr. Abhijit Debnath; Mr. Mohit Sharma; Dr. Chandana Majee; Mrs. Neha Sharma; Dr. Swarupanjali Padhi; Mrs. Archana Sharma; and Mrs. Nidhi Sharma.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present invention discloses a process for preparing a hydrogel formulation of Apigenin and Kaempferol against Ulcerative Colitis, said process comprising of sprinkling a predefined quantity of cross-linked polyacrylic acid polymer slowly into a predefined quantity of solvent; hydrating the solvent for 2-3 hours at room temperature to form hydrated solution; dissolving a predefined quantity of Apigenin and Kaempferol in a predefined quantity of Co-solvent and penetration enhancer and solublizer to form a drug solution; stirring the drug solution until a clear and uniform dispersion is obtained; dissolving a predefined quantity of preservatives in a warm water to prepare preservative solution; incorporating the drug solution into hydrated solution with gentle stirring and then adding the preservative solution; adding a predefined quantity of emulsifier and neutralizing agent dropwise in the solution with gentle stirring to form a Hydrogel.
Disclaimer: Curated by HT Syndication.
